Addiction: all studies (page 24) - The Consciousness Library

Mindfulness as a Path to Freedom from Internet Addiction in Adolescents: A Narrative Review.

Cureus October 1, 2024 Priyadarsini Samanta, Ipsa Mohapatra, Rituparna Mitra et al. 6 citations

In recent years, Internet Addiction Disorder (IAD) has become a major mental health concern among adolescents, with detrimental effects on social relationships, academic performance, and emotional well-being. The focus of mindfulness-based interventions (MBIs) on improving self-awareness, emotional regulation, and cognitive flexibility has drawn interest in MBIs as possible therapeutic...

DOI: 10.7759/cureus.72544 Full text Mindfulness Adolescents Emotional regulation Executive functioning +3

Drug dependence and prescribing ketamine for treatment-resistant depression in Australia and New Zealand.

Australian & New Zealand Journal of Psychiatry October 1, 2024 Alistair Carroll, Adam Bayes, Mark Montebello et al. 10 citations

Ketamine is a restricted and regulated medication in Australia and New Zealand, which has implications when considering treatment for patients with treatment-resistant depression and a history of illicit drug use, abuse or dependence. Regulations governing prescription of ketamine for treatment-resistant depression vary between jurisdictions in Australia and New Zealand, though most restrict...

DOI: 10.1177/00048674241242315 Full text Drug dependence Regulations Ketamine therapy Mental health treatment +3

Design and methodology of the first open-label trial of MDMA-assisted therapy for veterans with post-traumatic stress disorder and alcohol use disorder: Considerations for a randomized controlled trial.

Contemporary Clinical Trials Communications October 1, 2024 Erica Eaton, Christy Capone, Brian J Gully et al. 2 citations

Posttraumatic stress disorder (PTSD) and alcohol use disorder (AUD) commonly co-occur and are associated with more severe symptomatology than either disorder alone, increased risk of suicide, and poorer response to existing treatments. A promising therapeutic intervention is the integration of 3,4-methylenedioxymethamphetamine (MDMA) and psychotherapy. The Food and Drug Administration (FDA)...

DOI: 10.1016/j.conctc.2024.101333 Full text Alcohol use disorder MDMA Posttraumatic stress disorder Psychedelic assisted therapy +7

Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges.

CNS Drugs October 1, 2024 Anton Gomez-Escolar, Daniel Folch-Sanchez, Joanna Stefaniuk et al. 16 citations

Mental health disorders and substance use disorders (SUDs) in particular, contribute greatly to the global burden of disease. Psychedelics, including entactogens and dissociative substances, are currently being explored for the treatment of SUDs, yet with less empirical clinical evidence than for other mental health disorders, such as depression or post-traumatic stress disorder (PTSD). In this...

DOI: 10.1007/s40263-024-01101-3 Full text Addiction treatment Clinical research Psychedelics Mental health therapy +1

Psychedelics: From Cave Art to 21st-Century Medicine for Addiction

European Addiction Research September 25, 2024 Ioanna A. Vamvakopoulou, David Nutt 13 citations

Background: Psychedelic substance use in ritualistic and ceremonial settings dates back as early as 8,500 BCE. Only in recent years, from the mid-20th century, we have seen the re-emergence of psychedelics in a therapeutic setting and more specifically for the treatment of addiction. This article aims to review research over the past 40 years using classic (psilocybin, lysergic acid...

DOI: 10.1159/000540062 Full text Addiction Mescaline Psilocybin Lysergic acid diethylamide +3

Disrupting Substance Use Disorder: The Chemistry of Iboga Alkaloids.

European journal of organic chemistry September 23, 2024 Alexander J Hughes, Charles R Hamelink, Steven D Townsend 5 citations

The iboga alkaloids are a family of monoterpene indole alkaloids first discovered from the root of Tabernanthe iboga. The major alkaloid constituent in the root, ibogaine, has garnered interest for its anti-addictive properties. Ibogaine has been shown to reduce opiate, amphetamine, alcohol, and nicotine self-administration in rodents. However, ibogaine itself is less than optimal as a...

DOI: 10.1002/ejoc.202400432 Full text Ibogaine Substance use disorder Iboga alkaloids Ibogamine +1

Ketamine Therapy in Patients of Alcohol Use Disorder: A Prospective Pilot Study to Evaluate Abstinence Rate with This Add-on Treatment Modality

Annals of Indian Psychiatry September 3, 2024 Nidhi Purushottum Marvania, Anto Leroy Rayan, Dhruti Vijaykumar Merchant et al. 3 citations

Background: Alcohol use disorders (AUDs) are emerging as a substance use disorder having various psychological and physical ill effects leading to hampering of individual’s productivity and functioning. Aims: The aim of this study was to evaluate the efficacy of ketamine in enhancing confidence levels to abstain from alcohol. Methods: Eighteen patients were administered ketamine intravenously...

DOI: 10.4103/aip.aip_110_24 Full text Alcohol use disorder Abstinence and craving Ketamine therapy Paired t-test

Self-transcendence through the lens of ontological addiction: correlates of prosociality, competitiveness and pro-nature behavior

Current Psychology September 1, 2024 Paul Barrows, William van Gordon, Miles Richardson

AbstractSelf-transcendence and the associated decrease in ego-centeredness are understood to foster altruistic and positive behaviors that promote prosociality and pro-environmental actions. However, the lack of an agreed valid and reliable measure of self-transcendence has posed difficulties in examining this subject. The main aim of this study was to use the recently developed Ontological...

DOI: 10.1007/s12144-024-06403-9

A preliminary investigation of the acute effects of delta-9-tetrahydrocannabinol on pain and opioid attentional bias among persons with opioid use disorder.

Journal of Psychiatric Research September 1, 2024 Noah R Wolkowicz, Mehmet Sofuoglu, Brian Pittman et al.

Attentional bias (AB) is believed to be an important factor in the development and maintenance of both opioid use disorder (OUD) and chronic pain. Cannabis and its main psychoactive constituent, delta-9-tetrahydrocannabinol (THC), produce analgesic effects via processes that are potentially relevant to AB and is commonly used by persons with OUD. This exploratory study investigated if THC...

DOI: 10.1016/j.jpsychires.2024.06.047 Full text

Intellectual Property of Psychedelics for Addiction Treatment: Enabling Access and Protecting Innovation Opportunities Through Preserving the Public Domain.

Journal of Studies on Alcohol and Drugs September 1, 2024 Sisi Li, Taylor Kurtzweil, Shahin Shams et al. 3 citations

Recent research has shown potential for psychedelic therapeutics as addiction treatments; however, some academic institutions, commercial entities, and individuals are attempting to monopolize psychedelic compounds through exploiting the patent process. This Perspective article describes efforts that have been devised to mitigate exclusionary patent practices pertinent to psychedelic...

DOI: 10.15288/jsad.22-00425 Full text